John Neylan

John Neylan

Hoofd Techniek/Wetenschap/O&O bij AKARI THERAPEUTICS, PLC
72 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

John F.
Neylan
is Chief Medical Officer & Executive Vice President at Akari Therapeutics Plc since 2022.
Formerly, Dr. Neylan was Chief Medical Officer & Senior Vice President at Angion Biomedica Corp.
from 2018 to 2022, Chief Medical Officer & Senior Vice President at Keryx Biopharmaceuticals, Inc. from 2015 to 2018, Vice President-Research & Development at Wyeth Research from 2000 to 2008, Director at Advances In Kidney Disease & Health, Senior Vice President-Clinical Development at Genzyme Corp., Professor at Emory University, Assistant Professor at the University of California, Davis, and President of The American Society of Transplantation.
Education includes undergraduate studies at Duke University and a doctorate from Rush Medical College.

Actieve functies van John Neylan

BedrijvenFunctieBegin
AKARI THERAPEUTICS, PLC Hoofd Techniek/Wetenschap/O&O 08-11-2022

Eerdere bekende functies van John Neylan

BedrijvenFunctieEinde
ANGN BIOM Hoofd Techniek/Wetenschap/O&O 15-08-2022
KERYX BIOPHARMACEUTICALS Hoofd Techniek/Wetenschap/O&O 12-12-2018
Corporate Officer/Principal 01-05-2008
Directeur/Bestuurslid -
President -
Ervaring van John Neylan in detail bekijken

Opleiding van John Neylan

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

55

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. John Neylan
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU